Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. （打开新窗口）

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

来源‎: Crit Care Med 2009;37(4):1299-307.

检索‎: PubMed 19242343

DOI码‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 （打开新窗口）

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. （打开新窗口）

Ball AM, Winstead PS.

来源‎: Pharmacotherapy 2008;28(11):1383-90.

检索‎: PubMed 18956998

DOI码‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 （打开新窗口）

Reducing postburn injury anemia in a Jehovah's Witness patient. （打开新窗口）

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

来源‎: J Burn Care Res 2014;35(4):e258-61.

检索‎: PubMed 24121804

DOI码‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 （打开新窗口）

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. （打开新窗口）

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

来源‎: Clin Ther 2008;30(12):2324-34.

检索‎: PubMed 19167591

DOI码‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 （打开新窗口）

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. （打开新窗口）

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

来源‎: Transplant Proc 2015;47(8):2548-51.

检索‎: PubMed 26518969

DOI码‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 （打开新窗口）

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. （打开新窗口）

Charles A, Purtill M, Napolitano LM.

来源‎: Anaesth Intensive Care 2006;34(6):793-6.

检索‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 （打开新窗口）

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. （打开新窗口）

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

来源‎: Crit Care Med 1999;27(11):2346-50.

检索‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 （打开新窗口）

Erythropoietin for critically ill trauma patients: a missed opportunity? （打开新窗口）

Corwin HL, Napolitano LM

来源‎: J Trauma Acute Care Surg 2014;77(5):774-9.

检索‎: PubMed 25494432

DOI码‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 （打开新窗口）

Postoperative management of severe acute anemia in a Jehovah's Witness. （打开新窗口）

de Araújo Azi LM, Lopes FM, Garcia LV

来源‎: Transfusion 2014;54(4):1153-7.

检索‎: PubMed 24117834

DOI码‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 （打开新窗口）

Restrictive transfusion in geriatric trauma patients. （打开新窗口）

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

来源‎: Am Surg 2016;82(1):85-8.

检索‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 （打开新窗口）

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. （打开新窗口）

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

来源‎: J Trauma 1998;44(2):361-7.

检索‎: PubMed 9498512

DOI码‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 （打开新窗口）

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. （打开新窗口）

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

来源‎: Crit Care 2005;9(5):R508-15.

检索‎: PubMed 16277712

DOI码‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 （打开新窗口）

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. （打开新窗口）

Hong T, Shander A, Agarwal S, Castresana M.

来源‎: A A Case Rep 2015;4(10):127-31.

检索‎: PubMed 25974416

DOI码‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 （打开新窗口）

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. （打开新窗口）

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

来源‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

检索‎: PubMed 35941026

DOI码‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ （打开新窗口）

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. （打开新窗口）

Lindholm J, Palmér K, Frenckner B.

来源‎: Perfusion 2012;27(4):332-4.

检索‎: PubMed 22496111

DOI码‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 （打开新窗口）

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. （打开新窗口）

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

来源‎: Am Surg 2010;76(9):951-6.

检索‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 （打开新窗口）

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. （打开新窗口）

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

来源‎: Intensive Care Med 2013;39(11):1896-908.

检索‎: PubMed 23928897

DOI码‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 （打开新窗口）

Transfusion-free treatment strategies for acute anemia in critical care. （打开新窗口）

Morgan CA, Byul Sarah S, Forest CP.

来源‎: JAAPA 2016;29(8):38-44.

检索‎: PubMed 27467297

DOI码‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 （打开新窗口）

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. （打开新窗口）

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

来源‎: J Trauma 2008;65(2):285-97.

检索‎: PubMed 18695463

DOI码‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 （打开新窗口）

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. （打开新窗口）

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

来源‎: J Trauma 2009;67(1):121-4.

检索‎: PubMed 19590320

DOI码‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 （打开新窗口）

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. （打开新窗口）

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

来源‎: Surg Infect (Larchmt) 2009;10(1):9-19.

检索‎: PubMed 19245362

DOI码‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 （打开新窗口）

How do we treat life-threatening anemia in a Jehovah's Witness patient? （打开新窗口）

Posluszny JA Jr, Napolitano LM.

来源‎: Transfusion 2014;54(12):3026-34.

检索‎: PubMed 25330835

DOI码‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 （打开新窗口）

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. （打开新窗口）

Price S, Pepper JR, Jaggar SI.

来源‎: Anesth Analg 2005;101(2):325-7.

检索‎: PubMed 16037136

DOI码‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 （打开新窗口）

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. （打开新窗口）

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

来源‎: Am Surg 2015;81(6):e263-5.

检索‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 （打开新窗口）

Erythropoietin response is blunted in critically ill patients. （打开新窗口）

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

来源‎: Intensive Care Med 1997;23(2):159-62.

检索‎: PubMed 9069000

DOI码‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 （打开新窗口）

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. （打开新窗口）

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

来源‎: Br J Anaesth 2005;94(4):442-4.

检索‎: PubMed 15653706

DOI码‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 （打开新窗口）

Management of anemia in patients who decline blood transfusion. （打开新窗口）

Shander A, Goodnough LT

来源‎: Am J Hematol 2018;93(9):1183-91.

检索‎: PubMed 30033541

DOI码‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ （打开新窗口）

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. （打开新窗口）

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

来源‎: Arch Surg 2012;147(3):251-5.

检索‎: PubMed 22430906

DOI码‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 （打开新窗口）

Intravenous iron following cardiac surgery does not increase the infection rate. （打开新窗口）

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

来源‎: Surg Infect (Larchmt) 2006;7(4):361-6.

检索‎: PubMed 16978079

DOI码‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 （打开新窗口）

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. （打开新窗口）

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

来源‎: Crit Care 2015;19:49.

检索‎: PubMed 25888250

DOI码‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 （打开新窗口）